Challenges with Estimating Long-Term Overall Survival in Extensive Stage Small-Cell Lung Cancer: A Validation-Based Case Study
Sukhvinder Johal,1 Lance Brannman,2 Victor Genestier,3 Hélène Cawston4 1Oncology Market Access and Pricing, AstraZeneca, Cambridge, UK; 2Oncology Market Access and Pricing, AstraZeneca, Gaithersburg, MD, USA; 3Health Economic and Outcomes Research, Amaris Consulting, Toronto, Ontario, Canada; 4Healt...
Main Authors: | Johal S, Brannman L, Genestier V, Cawston H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-02-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/challenges-with-estimating-long-term-overall-survival-in-extensive-sta-peer-reviewed-fulltext-article-CEOR |
Similar Items
-
Impact of metastatic organ on prognosis in extensive-stage small cell lung cancer
by: LIU Qian , QIAO Meng , MAO Shiqi , YANG Shuo , LIU Yiwei , ZHAO Chao , LI Xuefei , REN Shengxiang , ZHOU Caicun
Published: (2021-01-01) -
Cost-effectiveness analysis of first-line serplulimab combined with chemotherapy for extensive-stage small cell lung cancer
by: Xueyan Liang, et al.
Published: (2023-08-01) -
Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
by: Chaoyuan Liu, et al.
Published: (2023-06-01) -
The efficacy of adebrelimab compared with durvalumab and atezolizumab in untreated extensive-stage small-cell lung cancer: a survival analysis of reconstructed patient-level data
by: Bi-Cheng Wang, et al.
Published: (2023-05-01) -
Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma
by: LJ Bakker, et al.
Published: (2023-05-01)